Literature DB >> 15491160

Truncated carboxyl-terminal fragments of beta-amyloid precursor protein are processed to amyloid beta-proteins 40 and 42.

Satoru Funamoto1, Maho Morishima-Kawashima, Yu Tanimura, Naoko Hirotani, Takaomi C Saido, Yasuo Ihara.   

Abstract

We previously showed that beta-amyloid precursor protein (APP) is cleaved not only in the middle of the membrane (gamma-cleavage) but also at novel cleavage sites close to the membrane/cytoplasmic boundary (epsilon-cleavage), releasing APP intracellular domains (AICDs) 49-99 and 50-99. To learn more about the relationship between gamma- and epsilon-cleavage, C-terminally truncated carboxyl-terminal fragments (CTFs) of APP, especially CTFs1-48 and 1-49 (the postulated products that are generated by epsilon-cleavage), were transiently expressed in CHO cells. Most importantly, the cells expressing CTF1-49 secreted predominantly amyloid beta-protein (Abeta) 40, while those expressing CTF1-48 secreted preferentially Abeta42. This supports our assumption that epsilon-cleavage precedes Alphabeta production and that preceding epsilon-cleavage determines the preference for the final Abeta species. The gamma-secretase inhibitors, L-685,458 and DAPT, suppressed Abeta production from CTF1-49. Regarding Abeta production from CTF1-48, L-685,458 suppressed it, but DAPT failed to do so. A dominant negative mutant of presenilin 1 suppressed the production of Abeta40 and 42 from both CTFs1-48 and 1-49. These data should shed significant light into the mechanism of Abeta production.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15491160     DOI: 10.1021/bi049399k

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  49 in total

1.  Aberrant amyloid precursor protein (APP) processing in hereditary forms of Alzheimer disease caused by APP familial Alzheimer disease mutations can be rescued by mutations in the APP GxxxG motif.

Authors:  Lisa-Marie Munter; Anne Botev; Luise Richter; Peter W Hildebrand; Veit Althoff; Christoph Weise; Daniela Kaden; Gerd Multhaup
Journal:  J Biol Chem       Date:  2010-05-07       Impact factor: 5.157

Review 2.  Cellular mechanisms of γ-secretase substrate selection, processing and toxicity.

Authors:  Gael Barthet; Anastasios Georgakopoulos; Nikolaos K Robakis
Journal:  Prog Neurobiol       Date:  2012-05-20       Impact factor: 11.685

Review 3.  Structure and mechanism of intramembrane protease.

Authors:  Ya Ha
Journal:  Semin Cell Dev Biol       Date:  2008-11-19       Impact factor: 7.727

4.  γ-Secretase processing and effects of γ-secretase inhibitors and modulators on long Aβ peptides in cells.

Authors:  Yong Ran; Pedro E Cruz; Thomas B Ladd; Abdul H Fauq; Joo In Jung; Julian Matthews; Kevin M Felsenstein; Todd E Golde
Journal:  J Biol Chem       Date:  2013-12-18       Impact factor: 5.157

Review 5.  Unraveling the complexity of γ-secretase.

Authors:  Michael S Wolfe
Journal:  Semin Cell Dev Biol       Date:  2020-01-21       Impact factor: 7.727

6.  Proteomic analysis of the amyloid precursor protein fragment C99: expression in yeast.

Authors:  Louis J Sparvero; Sarah Patz; Jeffrey L Brodsky; Christina M Coughlan
Journal:  Anal Biochem       Date:  2007-08-10       Impact factor: 3.365

7.  Dissociation between the processivity and total activity of γ-secretase: implications for the mechanism of Alzheimer's disease-causing presenilin mutations.

Authors:  Omar Quintero-Monzon; Morgan M Martin; Marty A Fernandez; Christina A Cappello; Amanda J Krzysiak; Pamela Osenkowski; Michael S Wolfe
Journal:  Biochemistry       Date:  2011-09-30       Impact factor: 3.162

Review 8.  Toward the structure of presenilin/γ-secretase and presenilin homologs.

Authors:  Michael S Wolfe
Journal:  Biochim Biophys Acta       Date:  2013-12

9.  Conformational changes induced by the A21G Flemish mutation in the amyloid precursor protein lead to increased Aβ production.

Authors:  Tzu-Chun Tang; Yi Hu; Pascal Kienlen-Campard; Laetitia El Haylani; Marie Decock; Joanne Van Hees; Ziao Fu; Jean-Noel Octave; Stefan N Constantinescu; Steven O Smith
Journal:  Structure       Date:  2014-01-23       Impact factor: 5.006

10.  Flavonoid-mediated presenilin-1 phosphorylation reduces Alzheimer's disease beta-amyloid production.

Authors:  Kavon Rezai-Zadeh; R Douglas Shytle; Yun Bai; Jun Tian; Huayan Hou; Takashi Mori; Jin Zeng; Demian Obregon; Terrence Town; Jun Tan
Journal:  J Cell Mol Med       Date:  2008-04-09       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.